134 related articles for article (PubMed ID: 2384007)
1. Inhibition of experimental autoimmune uveoretinitis by mercuric chloride injections in (Lewis x Brown Norway) F1 hybrid rats.
Saoudi A; Bellon B; de Kozak Y; Vial MC; Thillaye B; Druet P
Curr Eye Res; 1990; 9 Suppl():135-8. PubMed ID: 2384007
[TBL] [Abstract][Full Text] [Related]
2. Prevention of experimental autoimmune uveoretinitis and experimental autoimmune pinealitis in (Lewis x Brown-Norway) F1 rats by HgCl2 injections.
Saoudi A; Bellon B; de Kozak Y; Kuhn J; Vial MC; Thillaye B; Druet P
Immunology; 1991 Oct; 74(2):348-54. PubMed ID: 1748484
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of experimental autoimmune uveoretinitis in HgCl2 injected rats.
Saoudi A; Bellon B; de Kozak Y; Druet P
Curr Eye Res; 1992; 11 Suppl():101-5. PubMed ID: 1424735
[TBL] [Abstract][Full Text] [Related]
4. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease.
Saoudi A; Kuhn J; Huygen K; de Kozak Y; Velu T; Goldman M; Druet P; Bellon B
Eur J Immunol; 1993 Dec; 23(12):3096-103. PubMed ID: 8258322
[TBL] [Abstract][Full Text] [Related]
5. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
6. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis.
Saoudi A; Hurez V; de Kozak Y; Kuhn J; Kaveri SV; Kazatchkine MD; Druet P; Bellon B
Int Immunol; 1993 Dec; 5(12):1559-67. PubMed ID: 8312226
[TBL] [Abstract][Full Text] [Related]
7. Ocular injection of retinal S antigen: suppression of autoimmune uveitis.
Mizuno K; Clark AF; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):772-4. PubMed ID: 2784789
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental autoimmune uveoretinitis by intrathymic S-antigen injection.
Koevary SB; Caspi RR
Ocul Immunol Inflamm; 1997 Sep; 5(3):165-72. PubMed ID: 9326761
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1265-71. PubMed ID: 2458329
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen.
Fox GM; Kuwabara T; Wiggert B; Redmond TM; Hess HH; Chader GJ; Gery I
Clin Immunol Immunopathol; 1987 May; 43(2):256-64. PubMed ID: 3494559
[TBL] [Abstract][Full Text] [Related]
11. Identification of a potent new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats.
Gregerson DS; Merryman CF; Obritsch WF; Donoso LA
Cell Immunol; 1990 Jun; 128(1):209-19. PubMed ID: 2344622
[TBL] [Abstract][Full Text] [Related]
12. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis.
Caspi RR; Chan CC; Fujino Y; Najafian F; Grover S; Hansen CT; Wilder RL
J Neuroimmunol; 1993 Sep; 47(2):177-88. PubMed ID: 8370769
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.
Vrabec TR; Gregerson DS; Dua HS; Donoso LA
Autoimmunity; 1992; 12(3):175-84. PubMed ID: 1343765
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression.
De Kozak Y; Mirshahi M
Int Ophthalmol; 1990 Jan; 14(1):43-56. PubMed ID: 2323893
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
17. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
[TBL] [Abstract][Full Text] [Related]
18. Modulation of experimental autoimmune uveoretinitis by adoptive transfer of cells from rats immunized with anti-S-antigen monoclonal antibody.
de Kozak Y; Mirshahi M; Boucheix C; Faure JP
Reg Immunol; 1989; 2(5):311-20. PubMed ID: 2485681
[TBL] [Abstract][Full Text] [Related]
19. Antigen-directed retention of an autoimmune T-cell line.
Lightman SL; Caspi RR; Nussenblatt RB; Palestine AG
Cell Immunol; 1987 Nov; 110(1):28-34. PubMed ID: 2960461
[TBL] [Abstract][Full Text] [Related]
20. Suppression of experimental autoimmune uveoretinitis by prazosin, an alpha 1-adrenergic receptor antagonist.
Ruiz-Moreno JM; Misiuk-Hojlo M; Thillaye B; de Kozak Y
Curr Eye Res; 1992; 11 Suppl():135-40. PubMed ID: 1424739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
